Comera Life Sciences Holdings Inc (CMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,965 | -2,879 | -5,452 | -3,428 | -2,514 |
| Depreciation Amortization | 46 | 25 | 86 | 62 | 43 |
| Accounts receivable | -100 | -148 | 110 | 110 | 110 |
| Accounts payable and accrued liabilities | 984 | 123 | 319 | 130 | -4 |
| Other Working Capital | 1,172 | -57 | 574 | 220 | 282 |
| Other Operating Activity | 4,328 | 67 | 604 | 752 | 862 |
| Operating Cash Flow | $-5,535 | $-2,870 | $-3,758 | $-2,154 | $-1,221 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | N/A | -142 | -12 | N/A |
| Investing Cash Flow | $-4 | $N/A | $-142 | $-12 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 750 | 750 | 750 |
| Common Stock Issued | 660 | 429 | 180 | 180 | N/A |
| Other Financing Activity | 3,307 | -207 | 9,350 | 9,350 | 7,240 |
| Financing Cash Flow | $3,967 | $223 | $10,280 | $10,280 | $7,990 |
| Beginning Cash Position | 6,560 | 6,560 | 180 | 180 | 180 |
| End Cash Position | 4,989 | 3,913 | 6,560 | 8,294 | 6,950 |
| Net Cash Flow | $-1,571 | $-2,647 | $6,380 | $8,114 | $6,769 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,535 | -2,870 | -3,758 | -2,154 | -1,221 |
| Capital Expenditure | -4 | 0 | -142 | -12 | N/A |
| Free Cash Flow | -5,538 | -2,870 | -3,900 | -2,166 | -1,221 |